• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌放射治疗中获益与局限的ROC分析

ROC analysis of benefit and limitation in radiotherapy for cancer of the oral cavity.

作者信息

Maciejewski B, Zajusz A, Rota L

机构信息

Centre of Oncology, M. Sklodowska-Curie, Memorial Institute, Gliwice, Poland.

出版信息

Neoplasma. 1993;40(3):181-4.

PMID:8350966
Abstract

The ROC analysis of optimalization of radiation treatment of cancer of the oral cavity was carried out. Material of 210 patients with squamous cell carcinoma (SCC) of the oral cavity was included into the study. Based on dose-response curves for tumor and late mucosal reactions, iso-utility curves and optimal k values were estimated. Optimal k values decreased from 0.792 to 0.584 with extension of overall treatment time from 35 to 49 days. It may suggest that the planning of additional dose to compensate tumor clonogens repopulation during prolonged treatment time does not improve therapeutic gain in radiotherapy for cancer of the oral cavity. The ROC is a useful model to estimate optimal radiation treatment for a given tumor because it is independent of any arbitrary consensus or theoretical assumption.

摘要

对口腔癌放射治疗优化进行了ROC分析。该研究纳入了210例口腔鳞状细胞癌(SCC)患者的资料。基于肿瘤和晚期黏膜反应的剂量反应曲线,估计了等效用曲线和最佳k值。随着总治疗时间从35天延长至49天,最佳k值从0.792降至0.584。这可能表明,在延长治疗时间期间规划额外剂量以补偿肿瘤克隆原细胞再增殖,并不能提高口腔癌放射治疗的治疗增益。ROC是一种有用的模型,可用于估计给定肿瘤的最佳放射治疗,因为它独立于任何任意的共识或理论假设。

相似文献

1
ROC analysis of benefit and limitation in radiotherapy for cancer of the oral cavity.口腔癌放射治疗中获益与局限的ROC分析
Neoplasma. 1993;40(3):181-4.
2
Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.同步整合加量调强放射治疗局部晚期头颈部鳞状细胞癌:II期临床结果
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87. doi: 10.1016/j.ijrobp.2004.03.010.
3
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.调强放射治疗在口腔癌术后治疗中的应用
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1096-103. doi: 10.1016/j.ijrobp.2008.05.024. Epub 2008 Aug 15.
4
Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients.口腔鳞状细胞癌的局部复发和第二原发性肿瘤:一项对500例患者的回顾性分析研究
Head Neck. 2009 Sep;31(9):1168-80. doi: 10.1002/hed.21088.
5
Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?对头颈部癌患者进行根治性放射治疗时,唾液腺和口腔所接受的辐射剂量能否预测患者自评的口干和唾液黏稠情况?
Radiother Oncol. 2005 Nov;77(2):164-71. doi: 10.1016/j.radonc.2005.10.002. Epub 2005 Oct 26.
6
The late effects on normal and malignant tissues from 7.5 MeV neutrons in the treatment of advanced mouth cancer.7.5兆电子伏中子治疗晚期口腔癌对正常组织和恶性组织的远期效应。
Bull Cancer. 1986;73(5):587-90.
7
Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.头颈部鳞状细胞癌的调强放射治疗——爱荷华大学的经验
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21. doi: 10.1016/j.ijrobp.2005.02.025.
8
Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.口腔临床淋巴结阴性鳞状细胞癌患者的治疗。
Jpn J Clin Oncol. 2008 Jun;38(6):395-401. doi: 10.1093/jjco/hyn048.
9
Impact of tumor repopulation on radiotherapy planning.肿瘤再增殖对放射治疗计划的影响。
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):220-7. doi: 10.1016/j.ijrobp.2004.09.043.
10
Current radiation therapy management issues in oral cavity cancer.口腔癌当前的放射治疗管理问题
Otolaryngol Clin North Am. 2006 Apr;39(2):365-80. doi: 10.1016/j.otc.2005.11.004.